SNUBI Research ::   (120 talks satisfying Presenter = )
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    Help

ADD NEW USER

:   ǥ:    /Ű:    ¥:   

2019-01:
14 Prediction censored data  TopicSem
17 Combination chemotherapy in advanced gastric cancer  SysBiol

2018-12:
06 TP53 mutation with SYNE2 or SON mutation had Synergistic effect for paclitaxel, and predictive for prognosis in urogenital cancer  TopicSem
11 FLASK micro web framework in python  xMutant
15 Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation     J.Club
26 TP53 synthetic cytotoxic network for paclitaxel is a biomarker for chemotherapeutic response and prognosis of urogenital cancer  Seminar

2018-11:
12 Linking the Regulatory Network of Gene Modules to Drug Sensitivity Reveals that Docetaxel and 5-FU Have a Synergistic Effect in Advanced Gastric Cancer  TopicSem
15 ConnectivityMAP database in CLUE portal  SysBiol

2018-10:
08 skin classification  xMutant
20 Synthetic Lethality-based Identifcation of Targets for Anticancer Drugs in the Human Signaling Network     J.Club

2018-09:
13 TP53 Paclitaxel SC Network is Prognostic Factor on Urogenital Cancers  SysBiol
27 NGS Sequencing to Detect Genetic Biomarker of Busulfan Induced Hepatotoxicity  TopicSem

2018-08:
11 Classifying tumors by supervised network propagation     J.Club
14 Basal like triple negative breast cancer is susceptible to drugs targeting cell cycle and histone acetylation.  xMutant
14 Basal like triple negative breast cancer is susceptible to drugs targeting cell cycle and histone acetylation.  xMutant
14 Basal like triple negative breast cancer is susceptible to drugs targeting cell cycle and histone acetylation.  xMutant
14 Basal like triple negative breast cancer is susceptible to drugs targeting cell cycle and histone acetylation.  xMutant
14 Basal like triple negative breast cancer is susceptible to drugs targeting cell cycle and histone acetylation.  xMutant
20 Synthetic Cytotoxic Network based Supervised Network Propagation Approach Can Identify Paclitaxel Response of Cell Lines  TopicSem

2018-07:
12 NGS biomarker for busulfan ADR  SysBiol
12 NGS biomarker for busulfan ADR  SysBiol
19 Bipartite approach for Metalab DRUG-ADR network  TopicSem

2018-06:
16 Individual specific edge-network analysis for disease prediction     J.Club
25 Link regulatory networks of gene modules to drug sensitivity reveals that Docetaxel and 5-FU have combined effects in advanced stage gastric cancer  TopicSem
26 Radiogenomics for TNBC: Relationship between Microarray profile and radiomics texture data  xMutant

2018-05:
01 WXS for leukemia busulfan-VOD  xMutant
17 Link regulatory networks of gene modules to drug sensitivity reveals that Docetaxel and 5-FU have opposite effects in advanced stage gastric cancer  TopicSem
24 A Next Generation Connectivity-Map L1000 for drug treatment profiles  SysBiol

2018-04:
09 Inference of Digenic Disruption Networks for Synthetic Cytotoxicity  TopicSem

2018-03:
12 Inference of Digenic Disruption Networks for Synthetic Cytotoxicity  TopicSem
24 Link synthetic lethality to drug sensitivity of cancer cells     J.Club
29 RS-ADR data portal development, Firebase & vue.js  SysBiol

2018-02:
01   xMutant
01 STRING NETWORK for Graph-CNN  xMutant
08 The comparative analysis of the gene regulatory network according to the pathological stages reveals the characteristics of metastasis in gastric cancer  SysBiol
28 WEX for Hepatic VOD and Network propagation  xMutant

2018-01:
06 Hybrid Approach of Relation Network and Localized Graph Convolutional Filtering for Breast Cancer Subtype Classification     J.Club
18 Synthetic Dosage Cytotoxicity for prioritization of chemotherapy  SysBiol
22 Inference of Digenic Disruption Networks for Synthetic Cytotoxicity  TopicSem

2017-12:
07 Non-linear model to predict cytotoxic drug response  SysBiol
20 Microarray data analysis of multi-center breast cancer patients with distant metastasis  TopicSem
21 Inference of candidate Synthetic Cytotoxic Drug (Pyrimethamine, Paclitaxel)  xMutant

2017-11:
09 K-CDM: Conversion of EMR data to OMOP format  SysBiol
09 Regularization Techniques to Detect Biomarker for Cytotoxic Anticancer Drugs  xMutant
20 Synthetic Genetic Targeting in Cancer Cell Vulnerability  TopicSem

2017-10:
09 Korean Clinical Imaging Guidelines and clinical decision support system  SysBiol
18 Analysis of samples according to the number of SDCS pairs  TopicSem
28 MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays     J.Club

2017-09:
06 SDL gene target drugs and drug sensitivity  TopicSem
14 miRNA analysis pipeline and report format  xMutant

2017-08:
12 Measuring intratumor heterogeneity by network entropy using RNA-seq data     J.Club

2017-07:
18 SDL pairs validation from cancer cell line data  xMutant
26 Validation a Synthetic Dosage Cancer Survival Pairs using a Genomics of Drug Sensitivity in Cancer database  TopicSem
31 Finding genes targeted by GDSC drugs  SysBiol

2017-06:
17 Supporting precision medicine by data mining across multi-disciplines: an integrative approach for generating comprehensive linkages between single nucleotide variants (SNVs) and drug-binding sites     J.Club
26 Data preprocessing for Gene Score, Overexpression and Methylation  TopicSem
26 A tool for discovering drug sensitivity and gene expression associations in cancer cells  SysBiol

2017-05:
17 Classification and segmentation in convolutional neural network   xMutant
29 Synthetic dosage cancer survival analysis: Methylation and Under-expression  TopicSem

2017-04:
01 Network perturbation by recurrent regulatory variants in cancer     J.Club
17 Genetic programming to infer the optimal gene scoring method to classify genes  TopicSem
17 Gastric cancer metastasis network analysis  SysBiol

2017-03:
06 Weakly supervised learning  SysBiol
13 Genetic programming to infer the optimal gene scoring method to classify gene  TopicSem
29 Classification and segmentation in convolutional neural network  xMutant

2017-02:
01 GeneScore calculation strategy  xMutant

2017-01:
09 Inference of Gene Scoring Method for Disease Gene Prediction using optimization  TopicSem
14 Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response     J.Club
16 Inference cancer drug prognosis via cell line model  SysBiol

2016-12:
05 Integrative analysis for identifying the best anticancer therapy based on genomic features  SysBiol
07 Genetic Programming Based Gene Scoring Method for Common-Complex disease Prediction  xMutant
14 Synthetic dosage cancer survival: pan-cancer analysis for systematic inference of negative genetic interaction  TopicSem

2016-11:
16 Synthetic dosage cancer survival gene pairs  TopicSem

2016-10:
15 Mutual exclusive network and inference target from drug sensitivity  xMutant
29 ENCAPP: elastic-net-based prognosis prediction and biomarker discovery for human cancers     J.Club

2016-09:
26 Synthetic dosage cancer survival  TopicSem
9 WGCNA Network analysis of Microarray data  SysBiol

2016-08:
03 Network Analysis of Dysfunctional Genes in Endodermal Cancers  TopicSem
06 A Landscape of Pharmacogenomic Interactions in Cancer     J.Club
15 Microarray analysis for stem cell differentication  xMutant
19 Synthetic Dosage Cancer Survival:a computational approach for identification of negative genetic interaction  Seminar

2016-07:
04 Pan-cancer Analysis for Disrupted Gene Network via Developmental Origins  TopicSem
25 Microarray analysis (Illumina), research results  SysBiol

2016-06:
06 Intratumor heterogeneity influences the interaction of neoplastic cells with ECM proteins  SysBiol
20 Intratumor heterogeneity influences the interaction of neoplastic cells with ECM proteins  xMutant

2016-05:
21 Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discovery     J.Club
25 Endodermal origin tumors correlate with the class of tumor suppressor gene mutation  TopicSem

2016-04:
18 Identification of Drug relative genes predictive of Cancer survival in Chemotheraphy agent  SysBiol
20 Synthetic Dosage Cancer Survival: a computational approach for identification of negative genetic interaction  TopicSem
25 Predicting metastasis related gene via intratumor heterogeneity of Lung cancer  xMutant

2016-03:
01 Genomic intra- and inter-tumor heterogeneity Softwares and post session research  xMutant
01 DGIdb Database review and research examples  SysBiol
07 Keystone symposia  Seminar
12 Erosion of Conserved Binding Sites in Personal Genomes Points to Medical Histories     J.Club
16 Synthetic dosage cancer survival analysis  TopicSem

2016-01:
05 SDCS results in accordance with z score threshold  xMutant
12 Plan for calculating intratumor heterogeneity  xMutant
16 Synthetic Dosage Cancer Survival Analysis  Seminar
25 Synthetic dosage cancer survival in LUAD  TopicSem

2015-12:
19 Pan-cancer analysis of the extent and consequences of intratumor heterogeneity     J.Club
22 How to use MuTect, ExomeCNV and EXPANDS.  xMutant
23 intratumor heterogeneity analysis  TopicSem

2015-11:
03 Overexpression using normal expression in SDL analysis  xMutant
23 Synthetic Cancer Survival by Dosage  TopicSem

2015-10:
13 Microarray-calcification analysis in 182 breast cancer patients  xMutant
14 Results of Synthetic Cancer Survival by Dosage  TopicSem
17 Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles     J.Club

2015-09:
07 Current_progress_of_the_SDL_analysis  TopicSem

2015-08:
21 Synthetic dosage lethality in LUAD  xMutant

2015-07:
11 Integration of somatic mutation, expression, and functional data reveals potential driver genes predictive of breast cancer survival     J.Club
17 Data manipulations and method for gene selection in SDL  xMutant
22 Data manipulations and method for gene selection in SDL  TopicSem

2015-06:
22 Synthetic Dosage Lethality in Lung Adenocarcinoma  TopicSem

2015-05:
09 Improved data analysis for the MinION nanopore sequencer     J.Club
18 RNAseq data Filtering and Normalization and SDL regression analysis  TopicSem

2015-04:
15 RNAseq Normalization and SDL regression analysis  TopicSem

2015-03:
16 What is overexpression in Synthetic dosage lethality  TopicSem

2015-02:
04 Identifying genetic interaction of synthetic dosage lethal genes with survival analysis  TopicSem
28 Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data     J.Club

2015-01:
26 SG14  Seminar

powered by SNUBI